raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:352312

Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement

Type
Category
Group
Group of disorders
Status
active

This term does not characterize a disease but a group of diseases. To learn about the diseases included under this term, you can consult the classifications.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDisorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement
frTrouble de la synthèse des phospholipides, sphingolipides et acides gras avec atteinte prédominante des muscles squelettiques
deStörung der Phospholipid-, Sphingolipid- und Fettsäure-Biosynthese mit vorwiegender Beteiligung der Skelettmuskeln
esTrastorno de la biosíntesis de fosfolípidos, esfingolípidos y ácidos grasos con afectación predominante del músculo esquelético
itDifetto della biosintesi dei fosfolipidi, degli sfingolipidi e degli acidi grassi con coinvolgimento muscolare prevalente
nlStoornis van fosfolipiden-, sfingolipiden- en vetzuurbiosynthese met overheersende betrokkenheid van de skeletspieren
ptDoença dos fosfolipídios, esfingolipídios e biossíntese de ácidos gordos com envolvimento predominante do músculo esquelético
plZaburzenie biosyntezy fosfolipidów, sfingolipidów i kwasów tłuszczowych dotyczące głównie mięśni szkieletowych
csPorucha biosyntézy fosfolipidů, sfingolipidů a mastných kyselin s predominantním poškozením kosterního svalstva
ukПорушення біосинтезу фосфоліпідів, сфінголіпідів та жирних кислот з переважним залученням скелетних мязів
zh磷脂、鞘脂和脂肪酸生物合成障碍以骨骼肌受累为主
trİskelet kası ağırlıklı olarak tutulumu ile seyreden fosfolipidler, sfingolipidler ve yağ asitleri biyosentezindeki bozukluk
2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
MONDO18120Evalidated
UMLSC5680991Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (5):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card